These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20556505)

  • 1. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer.
    Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Lee AH; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 May; 127(1):99-108. PubMed ID: 20556505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients.
    Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L
    Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
    Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
    Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
    Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
    J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.
    Ladoire S; Mignot G; Dabakuyo S; Arnould L; Apetoh L; Rébé C; Coudert B; Martin F; Bizollon MH; Vanoli A; Coutant C; Fumoleau P; Bonnetain F; Ghiringhelli F
    J Pathol; 2011 Jul; 224(3):389-400. PubMed ID: 21437909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
    Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
    Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
    Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
    Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
    Giatromanolaki A; Bates GJ; Koukourakis MI; Sivridis E; Gatter KC; Harris AL; Banham AH
    Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
    Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
    Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
    Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
    Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.
    Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D
    Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
    Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
    Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3 and survival in urinary bladder cancer.
    Winerdal ME; Marits P; Winerdal M; Hasan M; Rosenblatt R; Tolf A; Selling K; Sherif A; Winqvist O
    BJU Int; 2011 Nov; 108(10):1672-8. PubMed ID: 21244603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer.
    Aruga T; Suzuki E; Saji S; Horiguchi S; Horiguchi K; Sekine S; Kitagawa D; Funata N; Toi M; Sugihara K; Kuroi K
    Oncol Rep; 2009 Aug; 22(2):273-8. PubMed ID: 19578766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
    Gupta S; Joshi K; Wig JD; Arora SK
    Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.